Trial ID or NCT#

NCT01645176

Status

NOT RECRUITING

Purpose

The purpose of this study of a combination therapy of hydroxychloroquine and atorvastatin is to learn about the effects in inflammation and pain in patients with Osteoarthritis of the knee. These medications are FDA approved and commercially available.

Official Title

Hydroxychloroquine/Atorvastatin in the Treatment of OA of the Knee

Eligibility Criteria

Ages Eligible for Study: Older than 40 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Mark Genovese
Rheumatologist
James W. Raitt M.D. Professor

Contact us to find out if this trial is right for you.

CONTACT

Rosario Villacorta
(650) 723-8516